<DOC>
	<DOC>NCT02087085</DOC>
	<brief_summary>This study will assess the safety and efficacy of the brimonidine intravitreal implant in patients with geographic atrophy due to age-related macular degeneration.</brief_summary>
	<brief_title>A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Geographic atrophy due to agerelated macular degeneration in the study eye Visual acuity better than or equal to 20/125 in the study eye and 20/200 in the fellow eye Cataract surgery or LaserAssisted in situ Keratomileusis (LASIK) in the study eye in the last 3 months Infections in either eye in the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>